SOMAVERT Side Effects

7022403-1 | Blood Growth Hormone Abnormal, Injection Site Reaction, Insulin-like Growth Factor Decreased
on Sep 27, 2010 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with acromegaly and was treated with Somavert (View Usage). Patient experienced the following unwanted or unexpected effects: blood growth hormone abnormal, injection site reaction, insulin-like growth factor decreased. Somavert dosage: 10 Mg, Daily. During the same period patient was treated with SYNTHROID (Unk) (View Synthroid Review and Synthroid Label ).

6984604-8 | Amnesia
Patient was taking Somavert (View Usage). Patient had the following side effects: amnesia on Sep 03, 2010 from GERMANY Additional patient health information: Female patient , 43 years of age, . Somavert dosage: Unk. During the same period patient was treated with ROCALTROL (Unk) (View Rocaltrol Review and Rocaltrol Label ), CALCIUM (Unk) (View Calcium Review and Calcium Label ), LEVOTHYROXINE SODIUM (Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6882008-X | Blood Potassium Decreased, Insulin-like Growth Factor Increased, Laboratory Test Abnormal
Adverse event was reported on Jul 20, 2010 by a Female patient taking Somavert (View Usage) (Dosage: 10 Mg, Unk) was diagnosed with acromegaly, hypertension and. Location: UNITED STATES , weighting 209.4 lb, After Somavert was administered, patient had the following side effects: blood potassium decreased, insulin-like growth factor increased, laboratory test abnormal. During the same period patient was treated with METOPROLOL (50 Mg, 1x/day) (View Metoprolol Review and Metoprolol Label ), HYDROCHLOROTHIAZIDE (25 Mg, 1x/day) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), VITAMIN B COMPLEX CAP (Unk) (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), MAGNESIUM (250 Mg, 1x/day) (View Magnesium Review and Magnesium Label ), CALCIUM (Unk, As Needed) (View Calcium Review and Calcium Label ), VITAMIN D (Unk, As Needed) (View Vitamin D Review and Vitamin D Label ).

6878282-6 | Headache, Neck Pain, Nuchal Rigidity, Sleep Disorder
on Jul 19, 2010 Female patient from GERMANY , 30 years of age, weighting 147.3 lb, was diagnosed with acromegaly and was treated with Somavert (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), neck pain, nuchal rigidity, sleep disorder (What is sleep disorder?). Somavert dosage: 10 Mg, 1x/day.


6822681-5 | Headache, Neck Pain, Nuchal Rigidity, Sleep Disorder
on Jul 05, 2010 Female patient from GERMANY , 30 years of age, was treated with Somavert (View Usage). Patient had the following side effects: headache (What is headache?), neck pain, nuchal rigidity, sleep disorder (What is sleep disorder?). Somavert dosage: Unk.

6805137-5 | Pituitary Tumour Benign
Patient was taking Somavert (View Usage). After Somavert was administered, patient had the following side effects: pituitary tumour benign on Aug 31, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 189.6 lb, was diagnosed with acromegaly and. Somavert dosage: .

6804702-9 | Injection Site Reaction
Adverse event was reported on May 29, 2007 by a Female patient taking Somavert (View Usage) (Dosage: ) was diagnosed with acromegaly and. Location: UNITED STATES , 34 years of age, Patient experienced the following unwanted or unexpected effects: injection site reaction.

6804590-0 | Alopecia, Dry Skin, Fatigue, Iron Deficiency Anaemia
on Apr 11, 2007 Female patient from UNITED STATES , weighting 125.0 lb, was diagnosed with pituitary tumour and was treated with Somavert (View Usage). Patient had the following side effects: alopecia, dry skin, fatigue, iron deficiency anaemia. Somavert dosage: . During the same period patient was treated with SANDOSTATIN (View Sandostatin Review and Sandostatin Label ).

6804495-5 | Weight Increased
on Apr 04, 2007 Female patient from UNITED STATES , weighting 145.1 lb, was diagnosed with acromegaly and was treated with Somavert (View Usage). After Somavert was administered, patient had the following side effects: weight increased. Somavert dosage: . During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), WARFARIN (View Warfarin Review and Warfarin Label ), PROCARDIA (View Procardia Review and Procardia Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6804395-0 | Angioedema, Injection Site Urticaria
Patient was taking Somavert (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema, injection site urticaria on May 09, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 147.9 lb, was diagnosed with acromegaly and. Somavert dosage: . During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), CLARINEX (View Clarinex Review and Clarinex Label ), BENADRYL (View Benadryl Review and Benadryl Label ), PERCOCET (View Percocet Review and Percocet Label ).

6804237-3 | Headache
Adverse event was reported on Jan 31, 2007 by a Male patient taking Somavert (View Usage) (Dosage: ) was diagnosed with pituitary tumour and. Location: UNITED STATES , weighting 250.0 lb, Patient had the following side effects: headache (What is headache?).

6804104-5 | Dyspnoea, Increased Appetite, Insomnia
on Mar 01, 2007 Male patient from UNITED STATES , weighting 360.0 lb, was diagnosed with acromegaly and was treated with Somavert (View Usage). After Somavert was administered, patient had the following side effects: dyspnoea, increased appetite, insomnia. Somavert dosage: Everyday. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LEVOTHROID (View Levothroid Review and Levothroid Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), BENADRYL (View Benadryl Review and Benadryl Label ).

6793579-6 | Injection Site Reaction
on Dec 09, 2008 Male patient from UNITED STATES , weighting 77.60 lb, was diagnosed with growth hormone-producing pituitary tumour and was treated with Somavert (View Usage). Patient experienced the following unwanted or unexpected effects: injection site reaction. Somavert dosage: . During the same period patient was treated with CABERGOLINE (View Cabergoline Review and Cabergoline Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

6792900-2 | Rash
Patient was taking Somavert (View Usage). Patient had the following side effects: rash (What is rash?) on Dec 06, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 184.3 lb, was diagnosed with acromegaly and. Somavert dosage: Unk.

6792596-X | Abdominal Discomfort, Condition Aggravated, Constipation, Injection Site Reaction
Adverse event was reported on Sep 23, 2008 by a Female patient taking Somavert (View Usage) (Dosage: ) was diagnosed with acromegaly and. Location: UNITED STATES , weighting 176.0 lb, After Somavert was administered, patient had the following side effects: abdominal discomfort, condition aggravated, constipation (What is constipation?), injection site reaction. During the same period patient was treated with SANDOSTATIN LAR (View Sandostatin Lar Review and Sandostatin Lar Label ).

6792360-1 | Insomnia
on Sep 26, 2008 Male patient from UNITED STATES , weighting 280.6 lb, was diagnosed with acromegaly, diabetes mellitus, hypertension and was treated with Somavert (View Usage). Patient experienced the following unwanted or unexpected effects: insomnia. Somavert dosage: . During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), TESTOSTERONE (View Testosterone Review and Testosterone Label ), TENORMIN (View Tenormin Review and Tenormin Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), CELEBREX (View Celebrex Review and Celebrex Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ).

6788574-7 | Endocrine Test Abnormal, Menorrhagia
on Apr 22, 2008 Female patient from UNITED STATES , weighting 280.6 lb, was diagnosed with acromegaly and was treated with Somavert (View Usage). Patient had the following side effects: endocrine test abnormal, menorrhagia. Somavert dosage: .

6787491-6 | Headache, Lipohypertrophy, Pituitary Tumour Benign
Patient was taking Somavert (View Usage). After Somavert was administered, patient had the following side effects: headache (What is headache?), lipohypertrophy, pituitary tumour benign on Oct 27, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 113.1 lb, was diagnosed with acromegaly and. Somavert dosage: Every Day. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), AVALIDE (View Avalide Review and Avalide Label ), AVAPRO (View Avapro Review and Avapro Label ), TOPAMAX (View Topamax Review and Topamax Label ), ZOMIG (View Zomig Review and Zomig Label ). Patient was hospitalized.

6768511-1 | Hepatic Function Abnormal, Pituitary Tumour Benign
Adverse event was reported on Jun 03, 2010 by a Female patient taking Somavert (View Usage) (Dosage: 40 Mg, 1x/day) was diagnosed with acromegaly and. Location: JAPAN , 37 years of age, weighting 114.6 lb, Patient experienced the following unwanted or unexpected effects: hepatic function abnormal, pituitary tumour benign.

6766275-9 | Renal Failure, Urinary Tract Infection Bacterial
on May 31, 2010 Male patient from FRANCE , 50 years of age, was diagnosed with acromegaly and was treated with Somavert (View Usage). Patient had the following side effects: renal failure, urinary tract infection bacterial. Somavert dosage: Unk. During the same period patient was treated with SOMATULINE (Unk) (View Somatuline Review and Somatuline Label ), BIGUANIDES (Unk) (View Biguanides Review and Biguanides Label ), SITAGLIPTIN (Unk) (View Sitagliptin Review and Sitagliptin Label ), STAGID (Unk) (View Stagid Review and Stagid Label ).

6734967-3 | Hepatic Function Abnormal, Pituitary Tumour Recurrent
on May 10, 2010 Female patient from JAPAN , 37 years of age, weighting 114.6 lb, was diagnosed with acromegaly and was treated with Somavert (View Usage). After Somavert was administered, patient had the following side effects: hepatic function abnormal, pituitary tumour recurrent. Somavert dosage: 40 Mg, 1x/day.

6731806-1 | Ovarian Cancer, Weight Increased
Patient was taking Somavert (View Usage). Patient experienced the following unwanted or unexpected effects: ovarian cancer, weight increased on May 07, 2010 from NORWAY Additional patient health information: Female patient , 68 years of age, . Somavert dosage: 20 Mg, 3 Times A Week. During the same period patient was treated with SANDOSTATIN LAR (Unk) (View Sandostatin Lar Review and Sandostatin Lar Label ).

6711459-9 | Arthritis, Inflammation
Adverse event was reported on Apr 23, 2010 by a Female patient taking Somavert (View Usage) (Dosage: Unk) was diagnosed with pituitary tumour and. Location: FRANCE , 66 years of age, Patient had the following side effects: arthritis (What is arthritis?), inflammation. Patient was hospitalized.

6684024-X | Hepatic Function Abnormal, Pituitary Tumour Recurrent
on Apr 05, 2010 Female patient from JAPAN , 37 years of age, was diagnosed with acromegaly and was treated with Somavert (View Usage). After Somavert was administered, patient had the following side effects: hepatic function abnormal, pituitary tumour recurrent. Somavert dosage: 10 Mg, 1x/day.

6616539-4 | Anaphylactic Shock
on Feb 22, 2010 Female patient from FRANCE , 46 years of age, was treated with Somavert (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock. Somavert dosage: 15 Mg, Single.

6608965-4 | Retinal Haemorrhage, Retinal Vein Occlusion
Patient was taking Somavert (View Usage). Patient had the following side effects: retinal haemorrhage, retinal vein occlusion on Feb 17, 2010 from TURKEY Additional patient health information: Female patient , 35 years of age, . Somavert dosage: 10 Mg, 1x/day. During the same period patient was treated with SANDOSTATIN LAR (Unk) (View Sandostatin Lar Review and Sandostatin Lar Label ), DELTACORTRIL (Unk) (View Deltacortril Review and Deltacortril Label ), LEVOTIRON (Unk) (View Levotiron Review and Levotiron Label ), MICARDIS (View Micardis Review and Micardis Label ).

6582800-5 | Cholelithiasis
Adverse event was reported on Feb 03, 2010 by a Female patient taking Somavert (View Usage) (Dosage: 20 Mg, 1x/day) . Location: SWEDEN , 54 years of age, After Somavert was administered, patient had the following side effects: cholelithiasis. During the same period patient was treated with SANDOSTATIN (Unk) (View Sandostatin Review and Sandostatin Label ). Patient was hospitalized.

6579585-5 | Arthritis, Inflammation
on Feb 02, 2010 Female patient from FRANCE , 66 years of age, was diagnosed with pituitary tumour and was treated with Somavert (View Usage). Patient experienced the following unwanted or unexpected effects: arthritis (What is arthritis?), inflammation. Somavert dosage: Unk. Patient was hospitalized.

6576966-0 | Retinal Haemorrhage
on Feb 02, 2010 Female patient from TURKEY , 34 years of age, was treated with Somavert (View Usage). Patient had the following side effects: retinal haemorrhage. Somavert dosage: 10 Mg, 1x/day.

6564845-4 | Lung Cancer Metastatic
Patient was taking Somavert (View Usage). After Somavert was administered, patient had the following side effects: lung cancer metastatic on Jan 19, 2010 from FRANCE Additional patient health information: Male patient , 45 years of age, was diagnosed with acromegaly and. Somavert dosage: .

6546578-3 | Arthritis, Inflammation
Adverse event was reported on Jan 13, 2010 by a Female patient taking Somavert (View Usage) (Dosage: Unk) . Location: FRANCE , 66 years of age, Patient experienced the following unwanted or unexpected effects: arthritis (What is arthritis?), inflammation.

6519526-X | Decreased Appetite, Respiratory Depression
on Dec 15, 2009 Male patient from JAPAN , 40 years of age, was diagnosed with acromegaly and was treated with Somavert (View Usage). Patient had the following side effects: decreased appetite, respiratory depression. Somavert dosage: 10 Mg, Twice A Week. During the same period patient was treated with SANDOSTATIN LAR (30 Mg, Monthly) (View Sandostatin Lar Review and Sandostatin Lar Label ), RISEDRONATE SODIUM HYDRATE (View Risedronate Sodium Hydrate Review and Risedronate Sodium Hydrate Label ), CORTRIL (View Cortril Review and Cortril Label ), THYRADIN (View Thyradin Review and Thyradin Label ), MOBIC (View Mobic Review and Mobic Label ), MYONAL (View Myonal Review and Myonal Label ), GLUTAMINE (View Glutamine Review and Glutamine Label ), MYSLEE (View Myslee Review and Myslee Label ).

6467359-5 | Bladder Cancer
on Nov 19, 2009 Male patient from CANADA , 54 years of age, was treated with Somavert (View Usage). After Somavert was administered, patient had the following side effects: bladder cancer (What is bladder cancer?). Somavert dosage: 15 Mg, Unk. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), CORTEF (View Cortef Review and Cortef Label ), TESTOSTERONE CIPIONATE (View Testosterone Cipionate Review and Testosterone Cipionate Label ).

6464570-4 | Decreased Appetite, Respiratory Depression
Patient was taking Somavert (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite, respiratory depression on Nov 19, 2009 from JAPAN Additional patient health information: Male patient , 40 years of age, was diagnosed with acromegaly and. Somavert dosage: 10 Mg, Twice A Week. During the same period patient was treated with SANDOSTATIN LAR (30 Mg, Monthly) (View Sandostatin Lar Review and Sandostatin Lar Label ), RISEDRONATE SODIUM HYDRATE (View Risedronate Sodium Hydrate Review and Risedronate Sodium Hydrate Label ), CORTRIL (View Cortril Review and Cortril Label ), THYRADIN (View Thyradin Review and Thyradin Label ), MOBIC (View Mobic Review and Mobic Label ), MYONAL (View Myonal Review and Myonal Label ), GLUTAMINE (View Glutamine Review and Glutamine Label ), MYSLEE (View Myslee Review and Myslee Label ).

6456029-5 | Labile Blood Pressure, Subarachnoid Haemorrhage
Adverse event was reported on Nov 17, 2009 by a Male patient taking Somavert (View Usage) (Dosage: 30 Mg, 1x/day) was diagnosed with acromegaly and. Location: IRELAND , 56 years of age, weighting 176.4 lb, Patient had the following side effects: labile blood pressure, subarachnoid haemorrhage. Patient was hospitalized.

6441844-4 | Respiratory Depression
on Nov 04, 2009 Male patient from JAPAN , 40 years of age, was diagnosed with acromegaly and was treated with Somavert (View Usage). After Somavert was administered, patient had the following side effects: respiratory depression. Somavert dosage: 10 Mg, Twice A Week. During the same period patient was treated with SANDOSTATIN LAR (30 Mg, Monthly) (View Sandostatin Lar Review and Sandostatin Lar Label ), RISEDRONATE SODIUM HYDRATE (View Risedronate Sodium Hydrate Review and Risedronate Sodium Hydrate Label ), CORTRIL (View Cortril Review and Cortril Label ), THYRADIN (View Thyradin Review and Thyradin Label ), MOBIC (View Mobic Review and Mobic Label ), MYONAL (View Myonal Review and Myonal Label ), GLUTAMINE (View Glutamine Review and Glutamine Label ), MYSLEE (View Myslee Review and Myslee Label ).

6425096-7 | Bladder Cancer
on Oct 22, 2009 Male patient from CANADA , 54 years of age, was diagnosed with acromegaly and was treated with Somavert (View Usage). Patient experienced the following unwanted or unexpected effects: bladder cancer (What is bladder cancer?). Somavert dosage: 15 Mg, Unk. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), CORTEF (View Cortef Review and Cortef Label ), TESTOSTERONE CIPIONATE (View Testosterone Cipionate Review and Testosterone Cipionate Label ).

6415734-7 | Subarachnoid Haemorrhage
Patient was taking Somavert (View Usage). Patient had the following side effects: subarachnoid haemorrhage on Oct 15, 2009 from IRELAND Additional patient health information: Female patient , 56 years of age, . Somavert dosage: 30 Mg, Unk.

6378780-8 | Acidosis
Adverse event was reported on Sep 16, 2009 by a Female patient taking Somavert (View Usage) (Dosage: ) was diagnosed with acromegaly and. Location: JAPAN , 37 years of age, After Somavert was administered, patient had the following side effects: acidosis. During the same period patient was treated with SANDOSTATIN LAR (View Sandostatin Lar Review and Sandostatin Lar Label ). Patient was hospitalized.

6361423-7 | Dysphagia, Oesophageal Adenocarcinoma, Weight Decreased
on Sep 04, 2009 Female patient from ITALY , 75 years of age, was diagnosed with acromegaly and was treated with Somavert (View Usage). Patient experienced the following unwanted or unexpected effects: dysphagia, oesophageal adenocarcinoma, weight decreased. Somavert dosage: 10 Mg, 1x/day. During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), NEBIVOLOL (View Nebivolol Review and Nebivolol Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

6329274-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Bilirubin Increased, Cardiac Disorder
on Aug 24, 2009 Male patient from UNITED STATES , weighting 242.0 lb, was diagnosed with acromegaly and was treated with Somavert (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, cardiac disorder. Somavert dosage: 30 Mg Daily Sq.

6305974-X | Cholecystitis Acute
Patient was taking Somavert (View Usage). After Somavert was administered, patient had the following side effects: cholecystitis acute on Aug 03, 2009 from FRANCE Additional patient health information: Female patient , 60 years of age, . Somavert dosage: Unk. During the same period patient was treated with LEVOTHYROX (Unk) (View Levothyrox Review and Levothyrox Label ), TRIMETAZIDINE (Unk) (View Trimetazidine Review and Trimetazidine Label ), LIPANTHYL (Unk) (View Lipanthyl Review and Lipanthyl Label ), GLUCOR (Unk) (View Glucor Review and Glucor Label ), HYDROCORTISONE (Unk) (View Hydrocortisone Review and Hydrocortisone Label ), KARDEGIC (Unk) (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6290976-2 | Dysphagia, Oesophageal Adenocarcinoma, Weight Decreased
Adverse event was reported on Jul 22, 2009 by a Female patient taking Somavert (View Usage) (Dosage: 10 Mg, 1x/day) was diagnosed with acromegaly and. Location: ITALY , 75 years of age, Patient experienced the following unwanted or unexpected effects: dysphagia, oesophageal adenocarcinoma, weight decreased. During the same period patient was treated with ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), NEBIVOLOL (View Nebivolol Review and Nebivolol Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

6252381-4 | Abdominal Pain, Abdominal Pain Upper, Dyspnoea, Headache, Hepatic Enzyme Increased, Hyperventilation, Pruritus, Rash Macular, Urine Colour Abnormal
on Jun 19, 2009 Female patient from UNITED KINGDOM , 37 years of age, was treated with Somavert (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), abdominal pain upper, dyspnoea, headache (What is headache?), hepatic enzyme increased, hyperventilation, pruritus, rash macular, urine colour abnormal. Somavert dosage: 30 Mg, 1x/day. During the same period patient was treated with HYDROCORTISONE (Daily) (View Hydrocortisone Review and Hydrocortisone Label ), LEVOTHYROXINE SODIUM (100 Ug, Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), TESTOSTERONE (View Testosterone Review and Testosterone Label ).

6217106-7 | Hypersensitivity
on May 26, 2009 Female patient from ITALY , 43 years of age, was diagnosed with acromegaly and was treated with Somavert (View Usage). After Somavert was administered, patient had the following side effects: hypersensitivity. Somavert dosage: 10 Mg, 1x/day. Patient was hospitalized.

6199450-5 | Cholecystitis Acute
Patient was taking Somavert (View Usage). Patient experienced the following unwanted or unexpected effects: cholecystitis acute on May 11, 2009 from FRANCE Additional patient health information: Female patient , 60 years of age, . Somavert dosage: Unk. During the same period patient was treated with LEVOTHYROX (Unk) (View Levothyrox Review and Levothyrox Label ), TRIMETAZIDINE (Unk) (View Trimetazidine Review and Trimetazidine Label ), LIPANTHYL (Unk) (View Lipanthyl Review and Lipanthyl Label ), GLUCOR (Unk) (View Glucor Review and Glucor Label ), HYDROCORTISONE (Unk) (View Hydrocortisone Review and Hydrocortisone Label ), KARDEGIC (Unk) (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6193665-8 | Arthralgia, Injection Site Erythema, Myalgia, Pyrexia
Adverse event was reported on May 06, 2009 by a Female patient taking Somavert (View Usage) (Dosage: 10 Mg, Unk) was diagnosed with acromegaly, thyroid disorder, headache (What is headache?) and. Location: FRANCE , 21 years of age, Patient had the following side effects: arthralgia, injection site erythema, myalgia, pyrexia. During the same period patient was treated with TETRALYSAL (150 Mg, 2x/day) (View Tetralysal Review and Tetralysal Label ), LEVOTHYROX (75 Ug, 1x/day) (View Levothyrox Review and Levothyrox Label ), TRAMADOL HCL (100mg, 2x/day) (View Tramadol Hcl Review and Tramadol Hcl Label ), SANDOSTATIN (Unk) (View Sandostatin Review and Sandostatin Label ). Patient was hospitalized and became disabled.

6038288-6 | Blood Potassium Increased, High Density Lipoprotein Increased, Troponin Increased
on Jan 06, 2009 Female patient from UNITED STATES , weighting 165.3 lb, was diagnosed with pituitary tumour and was treated with Somavert (View Usage). After Somavert was administered, patient had the following side effects: blood potassium increased, high density lipoprotein increased, troponin increased. Somavert dosage: 30 Mg, 1x/day. During the same period patient was treated with COREG (Unk) (View Coreg Review and Coreg Label ), ACETYLSALICYLIC ACID (Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), BENAZEPRIL HYDROCHLORIDE (Unk) (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ). Patient was hospitalized.

6026990-1 | Blood Potassium Increased, High Density Lipoprotein Increased, Troponin Increased
on Dec 08, 2008 Female patient from UNITED STATES , weighting 165.3 lb, was diagnosed with pituitary tumour and was treated with Somavert (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium increased, high density lipoprotein increased, troponin increased. Somavert dosage: 30 Mg, 1x/day. During the same period patient was treated with COREG (Unk) (View Coreg Review and Coreg Label ), ACETYLSALICYLIC ACID (Unk) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), BENAZEPRIL HYDROCHLORIDE (Unk) (View Benazepril Hydrochloride Review and Benazepril Hydrochloride Label ). Patient was hospitalized.

5971228-4 | Blood Pressure Increased, Coordination Abnormal, Emotional Distress, Hunger, Hypoglycaemia, Panic Reaction, Tremor
Patient was taking Somavert (View Usage). Patient had the following side effects: blood pressure increased, coordination abnormal, emotional distress, hunger, hypoglycaemia, panic reaction, tremor on Nov 20, 2008 from NETHERLANDS Additional patient health information: Female patient , weighting 136.7 lb, was diagnosed with acromegaly and. Somavert dosage: . During the same period patient was treated with CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), SANDOSTATIN (View Sandostatin Review and Sandostatin Label ), MOVICOLON (View Movicolon Review and Movicolon Label ), FERROUS FUMARATE (View Ferrous Fumarate Review and Ferrous Fumarate Label ). Patient was hospitalized.